Open AccessAdrenal Cushing’s Syndrome Treated With Preoperative Osilodrostat and Adrenalectomy
Author(s) -
Risha B. Malik,
Anat Ben-Shlomo
Publication year - 2022
Publication title -
aace clinical case reports
Language(s) - English
Resource type - Journals
ISSN - 2376-0605
DOI - 10.1016/j.aace.2022.10.001
Subject(s) - medicine , adrenalectomy , dexamethasone , morning , endocrinology , vomiting , cushing's disease , nausea , diabetes mellitus , adrenal adenoma , adrenocortical adenoma , adenoma , disease
Reducing severity of Cushing's syndrome caused by an adrenal adenoma (adrenal Cushing's syndrome [ACS]) might decrease morbidity and mortality risk in adrenalectomy. We used off-label osilodrostat, approved in the United States for pituitary Cushing's disease, to reduce cortisol levels and disease severity before adrenalectomy 3 weeks later.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom